Cargando…

The Solute Carrier MFSD1 Decreases the Activation Status of β1 Integrin and Thus Tumor Metastasis

Solute carriers are increasingly recognized as participating in a plethora of pathologies, including cancer. We describe here the involvement of the orphan solute carrier Major Facilitator Superfamily Domain-containing protein 1 (MFSD1) in the regulation of tumor cell migration. Loss of MFSD1 enable...

Descripción completa

Detalles Bibliográficos
Autores principales: Roblek, Marko, Bicher, Julia, van Gogh, Merel, György, Attila, Seeböck, Rita, Szulc, Bozena, Damme, Markus, Olczak, Mariusz, Borsig, Lubor, Siekhaus, Daria E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8861502/
https://www.ncbi.nlm.nih.gov/pubmed/35211397
http://dx.doi.org/10.3389/fonc.2022.777634
_version_ 1784654902240215040
author Roblek, Marko
Bicher, Julia
van Gogh, Merel
György, Attila
Seeböck, Rita
Szulc, Bozena
Damme, Markus
Olczak, Mariusz
Borsig, Lubor
Siekhaus, Daria E.
author_facet Roblek, Marko
Bicher, Julia
van Gogh, Merel
György, Attila
Seeböck, Rita
Szulc, Bozena
Damme, Markus
Olczak, Mariusz
Borsig, Lubor
Siekhaus, Daria E.
author_sort Roblek, Marko
collection PubMed
description Solute carriers are increasingly recognized as participating in a plethora of pathologies, including cancer. We describe here the involvement of the orphan solute carrier Major Facilitator Superfamily Domain-containing protein 1 (MFSD1) in the regulation of tumor cell migration. Loss of MFSD1 enabled higher levels of metastasis in experimental and spontaneous metastasis mouse models. We identified an increased migratory potential in MFSD1(−/−) tumor cells which was mediated by increased focal adhesion turnover, reduced stability of mature inactive β1 integrin, and the resulting increased integrin activation index. We show that MFSD1 promoted recycling to the cell surface of endocytosed inactive β1 integrin and thereby protected β1 integrin from proteolytic degradation; this led to dampening of the integrin activation index. Furthermore, downregulation of MFSD1 expression was observed during the early steps of tumorigenesis, and higher MFSD1 expression levels correlate with a better cancer patient prognosis. In sum, we describe a requirement for endolysosomal MFSD1 in efficient β1 integrin recycling to suppress tumor cell dissemination.
format Online
Article
Text
id pubmed-8861502
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-88615022022-02-23 The Solute Carrier MFSD1 Decreases the Activation Status of β1 Integrin and Thus Tumor Metastasis Roblek, Marko Bicher, Julia van Gogh, Merel György, Attila Seeböck, Rita Szulc, Bozena Damme, Markus Olczak, Mariusz Borsig, Lubor Siekhaus, Daria E. Front Oncol Oncology Solute carriers are increasingly recognized as participating in a plethora of pathologies, including cancer. We describe here the involvement of the orphan solute carrier Major Facilitator Superfamily Domain-containing protein 1 (MFSD1) in the regulation of tumor cell migration. Loss of MFSD1 enabled higher levels of metastasis in experimental and spontaneous metastasis mouse models. We identified an increased migratory potential in MFSD1(−/−) tumor cells which was mediated by increased focal adhesion turnover, reduced stability of mature inactive β1 integrin, and the resulting increased integrin activation index. We show that MFSD1 promoted recycling to the cell surface of endocytosed inactive β1 integrin and thereby protected β1 integrin from proteolytic degradation; this led to dampening of the integrin activation index. Furthermore, downregulation of MFSD1 expression was observed during the early steps of tumorigenesis, and higher MFSD1 expression levels correlate with a better cancer patient prognosis. In sum, we describe a requirement for endolysosomal MFSD1 in efficient β1 integrin recycling to suppress tumor cell dissemination. Frontiers Media S.A. 2022-02-08 /pmc/articles/PMC8861502/ /pubmed/35211397 http://dx.doi.org/10.3389/fonc.2022.777634 Text en Copyright © 2022 Roblek, Bicher, van Gogh, György, Seeböck, Szulc, Damme, Olczak, Borsig and Siekhaus https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Roblek, Marko
Bicher, Julia
van Gogh, Merel
György, Attila
Seeböck, Rita
Szulc, Bozena
Damme, Markus
Olczak, Mariusz
Borsig, Lubor
Siekhaus, Daria E.
The Solute Carrier MFSD1 Decreases the Activation Status of β1 Integrin and Thus Tumor Metastasis
title The Solute Carrier MFSD1 Decreases the Activation Status of β1 Integrin and Thus Tumor Metastasis
title_full The Solute Carrier MFSD1 Decreases the Activation Status of β1 Integrin and Thus Tumor Metastasis
title_fullStr The Solute Carrier MFSD1 Decreases the Activation Status of β1 Integrin and Thus Tumor Metastasis
title_full_unstemmed The Solute Carrier MFSD1 Decreases the Activation Status of β1 Integrin and Thus Tumor Metastasis
title_short The Solute Carrier MFSD1 Decreases the Activation Status of β1 Integrin and Thus Tumor Metastasis
title_sort solute carrier mfsd1 decreases the activation status of β1 integrin and thus tumor metastasis
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8861502/
https://www.ncbi.nlm.nih.gov/pubmed/35211397
http://dx.doi.org/10.3389/fonc.2022.777634
work_keys_str_mv AT roblekmarko thesolutecarriermfsd1decreasestheactivationstatusofb1integrinandthustumormetastasis
AT bicherjulia thesolutecarriermfsd1decreasestheactivationstatusofb1integrinandthustumormetastasis
AT vangoghmerel thesolutecarriermfsd1decreasestheactivationstatusofb1integrinandthustumormetastasis
AT gyorgyattila thesolutecarriermfsd1decreasestheactivationstatusofb1integrinandthustumormetastasis
AT seebockrita thesolutecarriermfsd1decreasestheactivationstatusofb1integrinandthustumormetastasis
AT szulcbozena thesolutecarriermfsd1decreasestheactivationstatusofb1integrinandthustumormetastasis
AT dammemarkus thesolutecarriermfsd1decreasestheactivationstatusofb1integrinandthustumormetastasis
AT olczakmariusz thesolutecarriermfsd1decreasestheactivationstatusofb1integrinandthustumormetastasis
AT borsiglubor thesolutecarriermfsd1decreasestheactivationstatusofb1integrinandthustumormetastasis
AT siekhausdariae thesolutecarriermfsd1decreasestheactivationstatusofb1integrinandthustumormetastasis
AT roblekmarko solutecarriermfsd1decreasestheactivationstatusofb1integrinandthustumormetastasis
AT bicherjulia solutecarriermfsd1decreasestheactivationstatusofb1integrinandthustumormetastasis
AT vangoghmerel solutecarriermfsd1decreasestheactivationstatusofb1integrinandthustumormetastasis
AT gyorgyattila solutecarriermfsd1decreasestheactivationstatusofb1integrinandthustumormetastasis
AT seebockrita solutecarriermfsd1decreasestheactivationstatusofb1integrinandthustumormetastasis
AT szulcbozena solutecarriermfsd1decreasestheactivationstatusofb1integrinandthustumormetastasis
AT dammemarkus solutecarriermfsd1decreasestheactivationstatusofb1integrinandthustumormetastasis
AT olczakmariusz solutecarriermfsd1decreasestheactivationstatusofb1integrinandthustumormetastasis
AT borsiglubor solutecarriermfsd1decreasestheactivationstatusofb1integrinandthustumormetastasis
AT siekhausdariae solutecarriermfsd1decreasestheactivationstatusofb1integrinandthustumormetastasis